Brian Schwartz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Burlington, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Brian Schwartz
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brian Schwartz

Form 4 holding Interim Chief Medical Officer, Director

Cyclacel Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
15,205
Estimated value
$50,405
Report date
29 Jan 2024
Price
$3.32
Ownership
Direct
Form 4 holding Director

INFINITY PHARMACEUTICALS, INC.

Security class
Stock Option(right to buy)
Shares / value
45,000
Estimated value
Report date
16 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Interim Chief Medical Officer, Director

Cyclacel Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,500
Estimated value
Report date
29 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brian Schwartz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .